Condition
Perioral Rhytids
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Recruiting1
Active Not Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06872359Not ApplicableActive Not Recruiting
Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling
NCT07492277Recruiting
A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines
NCT03923634Not ApplicableCompleted
Princess® RICH for the Correction of Fine Lines
NCT03092219Not ApplicableCompletedPrimary
RHA Redensity - Perioral Rhytids
NCT02818556Phase 4UnknownPrimary
A Clinical Study Comparing Restylane® Silk and Belotero Balance® for the Treatment of Superficial, Vertical Perioral Lines
Showing all 5 trials